Alexamorelin vs Ipamorelin — Peptide Comparison

Alexamorelin vs Ipamorelin — Peptide Comparison Alexamorelin vs Ipamorelin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Alexamorelin 100–300 mcg Ipamorelin Frequency Multiple times daily Administration Subcutaneous injection Cycle Length 4-6 weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Moderate human trials (Phase 1-2) Efficacy Growth Hormone Release Hormone Axis Stimulation Research & Innovation GH Selectivity Recovery Support Safety Profile Technical Data Molecular Formula C50H63N13O7 Molecular Weight 958.1 g/mol Half-Life Estimated 1-3 hours (rapidly metabolized to hexarelin) Bioavailability Active IV and orally; subcutaneous bioavailability expected moderate to good CAS Number 196808-85-2 C38H49N9O5 711.85 g/mol 2 hours High when injected subcutaneously 170851-70-4 Protocols starting 1.0 mcg/kg Single bolus per test session Single-dose research study Alexamorelin is a research growth-hormone-releasing peptide. In the main human study it was given as a single shot into a vein. The lower 1.0 mcg/kg dose raised growth hormone levels. [1] standard 2.0 mcg/kg The higher IV dose used in the same human study produced a stronger growth hormone response. [1] 20 mg (about 300 mcg/kg) Single dose Alexamorelin also works by mouth. A 20 mg oral dose (roughly 300 mcg/kg) released growth hormone in the human study, showing it stays active when swallowed. [1][3] 100 mcg per injection 2-3 times daily 4-8 weeks Conservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up. 200 mcg per injection Most commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2]. advanced 300 mcg per injection 3 times daily Upper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1]. Applications Muscle Builders and Athletes Alexamorelin's potent GH release makes it ideal for those serious about muscle gains. Its stronger ACTH response compared to hexarelin provides additional recovery benefits, though the cortisol elevation requires monitoring. The oral option is convenient for athletes avoiding injections, though subcutaneous injection remains most practical. Research-Focused Peptide Users If you're exploring next-generation GHS compounds, alexamorelin offers a fascinating case study: it's a prodrug that becomes hexarelin in your body, offering a unique window into peptide metabolism. This makes it valuable for understanding how compound modifications affect potency and half-life. Synergistic Stack Enthusiasts Alexamorelin shines when stacked with GHRH, creating synergistic GH release that exceeds either alone. It also pairs well with recovery-focused peptides like BPC-157, making it the centerpiece of comprehensive growth protocols. Clean GH Boost Seekers If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release. Recovery-Focused Athletes Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects. Anti-Aging Enthusiasts Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy. Those Recovering from Steroid Use Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost. Common Increased Hunger Water Retention Injection Site Reactions Uncommon Cortisol-Related Mood Changes Joint or Muscle Aches Serious Allergic Reaction Mild headache Injection site reactions Water retention Increased appetite Tingling in hands or feet Joint stiffness Allergic reaction Research Status FDA Status Research compound Safety Overview Alexamorelin is a research compound with only one small human study (6 subjects), making it much less proven than hexarelin. While it shows promise as a potent GH releaser, the limited human evidence means we don't fully understand long-term effects, optimal dosing in different populations, or rare side effects. Its unique stronger ACTH and aldosterone effects require careful monitoring. Always start low and monitor how your body responds. Contraindications xActive malignancy or cancer history (GH stimulation concern) xUncontrolled diabetes or severe glucose dysregulation xSevere cardiovascular disease or unmanaged hypertension xPregnancy or nursing Ipamorelin has shown a favorable safety profile in both animal and human studies. What makes it stand out is its remarkable selectivity—it releases growth hormone without significantly affecting cortisol, ACTH, or other hormones. In clinical trials, it was well-tolerated with mostly mild, temporary side effects. Phase 2 trials in patients recovering from surgery showed no significant safety concerns compared to placebo. xActive cancer or history of cancer xPregnancy or breastfeeding xPituitary disorders or tumors xKnown allergy to peptide components xChildren and adolescents (growth plates still open) Decision Guide Choose Alexamorelin if... Maximizing growth hormone release for muscle building Cycling with other peptides for synergistic GH stack effects Research into next-generation GHS compounds Understanding prodrug metabolism in peptide design Choose Ipamorelin if... Muscle recovery and growth Anti-aging and vitality Body composition improvement Sleep quality enhancement